Accès gratuit
Med Sci (Paris)
Volume 31, Numéro 5, Mai 2015
Page(s) 493 - 498
Section M/S Revues
Publié en ligne 9 juin 2015
  1. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003 ; 198 : 977–985. [CrossRef] [PubMed]
  2. Zhao L, Yamaguchi Y, Sharif S, et al. Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J Biol Chem 2011 ; 286 : 39520–39527. [CrossRef] [PubMed]
  3. Stejskal D, Karpisek M, Hanulova Z, Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population: a pilot study. Biomed Pap Med Fac 2008 ; 152 : 217–221. [CrossRef]
  4. Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005 ; 280 : 34661–34666. [CrossRef] [PubMed]
  5. Hansen IR, Jansson KM, Cannon B, et al. Contrasting effects of cold acclimation versus obesogenic diets on chemerin gene expression in brown and brite adipose tissues. Biochim Biophys Acta 2014 ; 1841 : 1691–1699. [CrossRef] [PubMed]
  6. Du XY, Leung LL. Proteolytic regulatory mechanism of chemerin bioactivity. Acta Biochim Biophys Sin (Shanghai) 2009 ; 41 : 973–979. [CrossRef] [PubMed]
  7. Mattern A, Zellmann T, Beck-Sickinger AG. Processing, signaling, and physiological function of chemerin. IUBMB Life 2014 ; 66 : 19–26. [CrossRef] [PubMed]
  8. Fatima SS, Rehman R, Baig M, et al. New roles of the multidimensional adipokine: chemerin. Peptides 2014 ; 62 : 15–20. [CrossRef] [PubMed]
  9. Parolini S, Santoro A, Marcenaro E, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007 ; 109 : 3625–3632. [CrossRef] [PubMed]
  10. Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007 ; 282 : 28175–28188. [CrossRef] [PubMed]
  11. Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009 ; 58 : 2731–2740. [CrossRef] [PubMed]
  12. Becker M, Rabe K, Lebherz C, et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 2010 ; 59 : 2898–2903. [CrossRef] [PubMed]
  13. Kaur J, Adya R, Tan BK, et al. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010 ; 39 : 1762–1768. [CrossRef]
  14. Marchese A, Docherty JM, Nguyen T, et al. Cloning of human genes encoding novel G-protein-coupled receptors. Genomics 1994 ; 23 : 609–618. [CrossRef] [PubMed]
  15. Shimizu N, Soda Y, Kanbe K, et al. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells. J Virol 1999 ; 73 : 5231–5239. [PubMed]
  16. Barnea G, Strapps W, Herrada G, et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008 ; 105 : 64–69. [CrossRef]
  17. Yoshimura T, Oppenheim JJ. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 2011 ; 317 : 674–684. [CrossRef] [PubMed]
  18. Zabel BA, Nakae S, Zuniga L, et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008 ; 205 : 2207–2220. [CrossRef] [PubMed]
  19. Monnier J, Lewen S, O’Hara E, et al. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J Immunol 2012 ; 189 : 956–967. [CrossRef]
  20. Ha YJ, Kang EJ, Song JS, et al. Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity. Joint Bone Spine 2014 ; 81 : 189–190. [CrossRef] [PubMed]
  21. Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 ; 148 : 4687–4694. [CrossRef] [PubMed]
  22. Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010 ; 72 : 342–348. [CrossRef] [PubMed]
  23. Parlee SD, Ernst MC, Muruganandan S, et al. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-alpha. Endocrinology 2010 ; 151 : 2590–2602. [CrossRef] [PubMed]
  24. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010 ; 21 : 660–667. [CrossRef] [PubMed]
  25. Roh SG, Song SH, Choi KC, et al. Chemerin: a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007 ; 362 : 1013–1018. [CrossRef] [PubMed]
  26. Rabe K1, Lehrke M, Parhofer KG, et al. Adipokines and insulin resistance. Mol Med 2008; 14 : 741–751. [PubMed]
  27. Ernst MC, Haidl ID, Zuniga LA, et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012; 153 : 672–682. [CrossRef] [PubMed]
  28. Rouger L, Denis GR, Luangsay S, et al. ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation. J Endocrinol 2013; 219 : 279–289. [CrossRef] [PubMed]
  29. Rourke JL, Muruganandan S, Dranse HJ, et al. Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice. J Endocrinol 2014 ; 222 : 201–215. [CrossRef] [PubMed]
  30. Kralisch S, Weise S, Sommer G, et al. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept 2009 ; 154 : 102–106. [CrossRef] [PubMed]
  31. Suzuki Y, Hong YH, Song SH, et al. The regulation of chemerin and CMKLR1 genes expression by TNF-alpha, adiponectin, and chemerin analog in bovine differentiated adipocytes. Asian-Australas J Anim Sci 2012 ; 25 : 1316–1321. [CrossRef] [PubMed]
  32. Zabel BA, Kwitniewski M, Banas M, et al. Chemerin regulation and role in host defense. Am J Clin Exp Immunol 2014 ; 3 : 1–19. [PubMed]
  33. Muruganandan S, Parlee SD, Rourke JL, et al. Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 2011 ; 286 : 23982–23995. [CrossRef] [PubMed]
  34. Bauer S, Wanninger J, Schmidhofer S, et al. Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 2011 ; 152 : 26–35. [CrossRef] [PubMed]
  35. Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res 2010 ; 25 : 222–234. [CrossRef] [PubMed]
  36. Tan BK, Chen J, Farhatullah S, et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009 ; 58 : 1971–1977. [CrossRef] [PubMed]
  37. Reverchon M, Cornuau M, Rame C, et al. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod 2012 ; 27 : 1790–1800. [CrossRef] [PubMed]
  38. Reverchon M, Bertoldo MJ, Rame C, et al. Chemerin (RARRES2) decreases in vitro granulosa cell steroidogenesis and blocks oocyte meiotic progression in bovine species. Biol Reprod 2014 ; 90 : 102. [CrossRef] [PubMed]
  39. Wang Q, Kim JY, Xue K, et al. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome. Endocrinology 2012 ; 153 : 5600–5611. [CrossRef] [PubMed]
  40. Kim JY, Xue K, Cao M, et al. Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone. Endocrinology 2013 ; 154 : 2912–2923. [CrossRef] [PubMed]
  41. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010 ; 25 : 544–551. [CrossRef] [PubMed]
  42. Guzel EC, Celik C, Abali R, et al. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecol Endocrinol 2014 ; 30 : 419–422. [CrossRef] [PubMed]
  43. Wang Q, Leader A, Tsang BK. Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology 2013 ; 154 : 956–967. [CrossRef] [PubMed]
  44. Li L, Ma P, Huang C, et al. Expression of chemerin and its receptors in rat testes and its action on testosterone secretion. J Endocrinol 2014 ; 220 : 155–163. [CrossRef] [PubMed]
  45. Li L, Huang C, Zhang X, et al. Chemerin-derived peptide C-20 suppressed gonadal steroidogenesis. Am J Reprod Immunol 2014 ; 71 : 265–277. [CrossRef]
  46. D’Ippolito S, Tersigni C, Scambia G, et al. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 2012 ; 38 : 14–23. [CrossRef] [PubMed]
  47. Noureldeen AF, Qusti SY, Al-Seeni MN, et al. Maternalleptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes. Indian J Clin Biochem 2014 ; 29 : 462–470. [CrossRef] [PubMed]
  48. Kasher-Meron M, Mazaki-Tovi S, Barhod E, et al. Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy. J Perinat Med 2014 ; 42 : 371–378. [CrossRef] [PubMed]
  49. Garces MF, Sanchez E, Acosta BJ, et al. Expression and regulation of chemerin during rat pregnancy. Placenta 2012 ; 33 : 373–378. [CrossRef] [PubMed]
  50. Garces MF, Sanchez E, Ruiz-Parra AI, et al. Serum chemerin levels during normal human pregnancy. Peptides 2013 ; 42 : 138–143. [CrossRef] [PubMed]
  51. Duan DM, Niu JM, Lei Q, et al. Serum levels of the adipokine chemerin in preeclampsia. J Perinat Med 2011 ; 40 : 121–127. [PubMed]
  52. Reverchon M, Ramé C, Bertoldo M, Dupont J. Adipokines and the female reproductive tract. Int J Endocrinol 2014 ; 2014 : 232454. [CrossRef] [PubMed]
  53. Foretz M, Viollet B. Les nouvelles promesses de la metformine. Med Sci (Paris) 2014 ; 30 : 82–92. [CrossRef] [EDP Sciences] [PubMed]
  54. Rigourd V, Chelbi ST, Vaiman D. La pré-éclampsie. Med Sci (Paris) 2008 ; 24 : 1017–1019. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.